BL22 Immunotoxin In Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma
- Status
- SUSPENDED
- Phase
- PHASE1
Clinical Trials Related to Lymphoma
Related studies linked through entity extraction aliases.
FR901228 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
Comparison of Fluconazole vs Voriconazole to Treat Fungal Infections for Blood and Marrow Transplants (BMT CTN 0101)
- Status
- COMPLETED
- Phase
- PHASE3
Comparing Fresh Random Platelets and Autologous Cryopreserved Thrombosol Treated Autologous Platelets
- Status
- TERMINATED
- Phase
- PHASE3
Donor Stem Cell Transplant With No or Low-Intensity Chemotherapy Using Sirolimus and Treated Immune Cells to Treat Blood and Lymph Cancers
- Status
- TERMINATED
- Phase
- PHASE2
Methotrexate, Procarbazine, Lomustine, Dexamethasone, and Cytarabine in Treating Patients With Primary CNS Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Methotrexate, Cyclophosphamide, and Etoposide Phosphate Given With Osmotic Blood-Brain Barrier Disruption Plus Dexamethasone and Cytarabine in Treating Patients With Primary CNS Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen
- Status
- TERMINATED
- Phase
- PHASE2
Liposomal Doxorubicin in Treating Patients With Stage IIB, Stage IVA, or Stage IVB Recurrent or Refractory Mycosis Fungoides
- Status
- COMPLETED
- Phase
- PHASE2
Y 90 Ibritumomab Tiuxetan &Rituximab Relapsed or Refractory Diffuse Large B-Cell Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Iodine I 131 Tositumomab Followed by Autologous Stem Cell Transplantation in Treating Older Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Whole-Body MRI and Conventional Imaging in Detecting Distant Metastases in Young Patients With Solid Tumors or Lymphoma
- Status
- UNKNOWN
- Phase
- NA
Rituximab in Treating Patients With Refractory or Relapsed Primary CNS Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Vaccine Therapy and Sargramostim After Rituximab in Treating Patients With Refractory or Progressive Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Pharmacokinetic Study of Palifermin in Subjects Receiving Radiation Therapy and Chemotherapy Followed by Blood Stem Cell Support
- Status
- COMPLETED
- Phase
- PHASE1
Rituximab, Prednisone, Cyclophosphamide, Doxorubicin, Vincristine, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Previously Untreated Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Study of @neWorld: A Virtual Community for Children With Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Gemcitabine and Vinorelbine in Treating Young Patients With Recurrent or Refractory Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2